APLT Stock Analysis: Buy, Sell, or Hold?

APLT - Applied Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.10
0.00 (0.19%) ▲
5d: +6.96%
30d: +3.0%
90d: -90.88%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Mar 13, 2026

Get Alerted When APLT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: APLT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

In-depth Analysis How we analyze

Valuation Analysis: APLT is currently trading at $0.10, which is considered fair relative to its 30-day fair value range of $0.10 to $0.11.

Technical Outlook: Technically, APLT is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $0.11.

Market Sentiment: APLT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.25 (+142.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $0.10 - $0.11
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 142.7% below Wall St target ($0.25)

Fair Price Analysis

30-Day Fair Range $0.10 - $0.11
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $0.09
Resistance Level $0.11
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -0.26
Wall Street Target $0.25 (+142.7%)
Revenue Growth (YoY) 719.7%
Last updated: February 04, 2026 2:05 AM ET
Data refreshes hourly during market hours. Next update: 3:05 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 67 BUY
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1036 58 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$33 65 BUY
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$117 61 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD

More Analysis for APLT

APLT Technical Chart APLT Price Prediction APLT Earnings Date APLT Investment Advisor APLT Fair Price Analyzer APLT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals